Charter Oak Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $803K | Sell |
1,979
-32
| -2% | -$13K | 0.07% | 89 |
|
|
2025
Q1 | $1M | Buy |
2,011
+1,422
| +241% | +$708K | 0.09% | 74 |
|
|
2024
Q4 | $306K | Buy |
589
+11
| +2% | +$5.72K | 0.03% | 141 |
|
|
2024
Q3 | $358K | Buy |
578
+23
| +4% | +$14.2K | 0.03% | 131 |
|
|
2024
Q2 | $307K | Sell |
555
-10
| -2% | -$5.53K | 0.03% | 139 |
|
|
2024
Q1 | $328K | Buy |
565
+10
| +2% | +$5.81K | 0.04% | 142 |
|
|
2023
Q4 | $294K | Hold |
555
| – | – | 0.04% | 143 |
|
|
2023
Q3 | $281K | Sell |
555
-16
| -3% | -$8.09K | 0.04% | 150 |
|
|
2023
Q2 | $298K | Buy |
571
+14
| +3% | +$7.31K | 0.04% | 148 |
|
|
2023
Q1 | $321K | Buy |
557
+3
| +0.5% | +$1.73K | 0.04% | 134 |
|
|
2022
Q4 | $305K | Sell |
554
-8
| -1% | -$4.41K | 0.05% | 136 |
|
|
2022
Q3 | $285K | Sell |
562
-82
| -13% | -$41.6K | 0.05% | 132 |
|
|
2022
Q2 | $350K | Buy |
644
+1
| +0.2% | +$543 | 0.05% | 132 |
|
|
2022
Q1 | $380K | Buy |
643
+50
| +8% | +$29.5K | 0.05% | 135 |
|
|
2021
Q4 | $396K | Sell |
593
-3
| -0.5% | -$2K | 0.05% | 133 |
|
|
2021
Q3 | $341K | Sell |
596
-25
| -4% | -$14.3K | 0.04% | 135 |
|
|
2021
Q2 | $313K | Hold |
621
| – | – | 0.04% | 138 |
|
|
2021
Q1 | $283K | Sell |
621
-15
| -2% | -$6.84K | 0.04% | 144 |
|
|
2020
Q4 | $296K | Buy |
+636
| New | +$296K | 0.04% | 133 |
|